[1] L. Colloca, T. Ludman, D. Bouhassira, R. Baron, A.H. Dickenson, D. Yarnitsky, R. Freeman, A. Truini, N. Attal, N.B. Finnerup, C. Eccleston, E. Kalso, D.L. Bennett, R.H. Dworkin, S.N. Raja, Neuropathic pain,
Nat. Rev. Dis. Prim.,
2017,
3. [
Crossref], [
Google Scholar], [
Publisher]
[2] N.P. Staff, A. Grisold, W. Grisold, A.J. Windebank, Chemotherapy-induced peripheral neuropathy: A current review,
Ann. Neurol.,
2017,
81, 772–781. [
Crossref], [
Google Scholar], [
Publisher]
[3] J. Burgess, M. Ferdousi, D. Gosal, C. Boon, K. Matsumoto, A. Marshall, T. Mak, A. Marshall, B. Frank, R.A. Malik, U. Alam, Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment,
Oncol. Ther.,
2021,
9, 385–450. [
Crossref], [
Google Scholar], [
Publisher]
[4] A.D. Desforges, C.M. Hebert, A.L. Spence B. Reid, H.A. Dhaibar, D. Cruz-Topete, E.M. Cornett, A.D. Kaye, I. Urits, O. Viswanath, Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update,
Biomed. Pharmacother.,
2022,
147, 112671. [
Crossref], [
Google Scholar], [
Publisher]
[5] H. Danesh, A. Bahmani, F. Moradi, B. Shirazipour, M. Milanifard, Pharmacological evaluation of Covid 19 vaccine in acute and chronic inflammatory neuropathies,
J. Med. Chem. Sci.,
2022,
5, 561–570. [
Crossref], [
Google Scholar], [
Publisher]
[6] E.S. Schwartz, J.H. La, N.N. Scheff, B.M. Davis, K.M. Albers, G.F. Gebhart, TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis,
J. Neurosci.,
2013,
33, 5603–5611. [
Crossref], [
Google Scholar], [
Publisher]
[7] J. Ann, H.S. Kim, S.A. Thorat, H. Kim, H.J. Ha, K. Choi, Y.H. Kim, M. Kim, S.W. Hwang, L.V. Pearce, T.E. Esch, N.A. Turcios, P.M. Blumberg, J. Lee, Discovery of nonpungent transient receptor potential vanilloid 1 (TRPV1) agonist as strong topical analgesic,
J. Med. Chem.,
2020,
63, 418–424. [
Crossref], [
Google Scholar], [
Publisher]
[8] J. Li, C. Nie, Y. Qiao, J. Hu, Q. Li, Q. Wang, X. Pu, L. Yan, H. Qian, Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists,
Eur. J. Med. Chem.,
2019,
178, 433–445. [
Crossref], [
Google Scholar], [
Publisher]
[9] A. Chukyo, T. Chiba, T. Kambe, K. Yamamoto, K. Kawakami, K. Taguchi, K. Abe, Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivit,
Neuropeptides,
2018,
67, 95–101. [
Crossref], [
Google Scholar], [
Publisher]
[10] J. Meng, S. Qiu, L. Zhang, M. You, H. Xing J. Zhu, Berberine alleviate cisplatin-induced peripheral neuropathy by modulating inflammation signal via TRPV1,
Front. Pharmacol.,
2022,
12, 1–14. [
Crossref], [
Google Scholar], [
Publisher]
[11] B. Kievit, A.D. Johnstone, J. Gibon, P.A. Barker, Mitochondrial reactive oxygen species mediate activation of TRPV1 and calcium entry fllowing peripheral sensory axotomy,
Front. Mol. Neurosci.,
2022,
15, 852181. [
Crossref], [
Google Scholar], [
Publisher]
[12] I.A. Khasabova, V.S. Seybold, D.A. Simone, The role of PPARγ in chemotherapy-evoked pain,
Neurosci. Lett.,
2021,
753. [
Crossref], [
Google Scholar], [
Publisher]
[13] L. Luongo, B. Costa, B. D’Agostino, F. Guida, F. Comelli, L. Gatta, M. Matteis, N. Sullo, L. De Petrocellis, V. De Novellis, S. Maione, V. Di Marzo, Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature,
Pharmacol. Res.,
2012,
66, 243–250. [
Crossref], [
Google Scholar], [
Publisher]
[14] M. Zhuo, Long-term potentiation in the anterior cingulate cortex and chronic pain,
Philos Trans. R Soc. B: Biol. Sci.,
2014,
369, 1–11. [
Crossref], [
Google Scholar], [
Publisher]
[15] J. Luo, A. Bavencoffe, P. Yang, J. Feng, S. Yin, A. Qian, W. Yu, S. Liu, X. Gong, T. Cai, E. T. Walters, C. W. Dessauer, & H. Hu, Zinc inhibits TRPV1 to alleviate chemotherapy-induced neuropathic pain,
J. Neurosci.,
2018,
38, 474. [
Crossref], [
Google Scholar], [
Publisher]
[16] Y. Zhang, F. Huang, Y. Xu, W. Xiang, C. Xie, TRPV1 is involved in the antinociceptive effects of resveratrol in paclitaxel-induced neuropathic pain,
All life,
2021,
14, 66–74. [
Crossref], [
Google Scholar], [
Publisher]
[17] A. Bhattacharya, P. Tiwari, P.K. Sahu, S. Kumar, A review of the phytochemical and pharmacological characteristics of Moringa oleifera,
J. Pharm. Bioallied. Sci.,
2018,
10, 181. [
Crossref], [
Google Scholar], [
Publisher]
[18] Y.W. Prajoko, S. Pramono, A. Hartanto, M.A. Prakoso, The effect of Moringa Oleifera extract on CPK and quality of life of breast cancer patients receiving aromatase inhibitor therapy,
J. Med. Chem. Sci.,
2023,
6, 2748–2753. [
Crossref], [
Pdf], [
Publisher]
[19] R.K. Saini, I. Sivanesan, Y.S. Keum, Phytochemicals of Moringa oleifera: a review of their nutritional, therapeutic and industrial significance,
3 Biotech,
2016,
6. [
Crossref], [
Google Scholar], [
Publisher]
[20] M.R. Sulaiman, Z.A. Zakaria, A.S. Bujarimin, M.N. Somchit, D.A. Israf, S. Moin, Evaluation of Moringa oleifera aqueous extract for antinociceptive and anti-inflammatory activities in animal models,
Pharm. Biol.,
2008,
4, 838–845. [
Crossref], [
Google Scholar], [
Publisher]
[21] I.N. Solomon, M.G. Kelechi, N.O. Chinenyenwa, Analgesic (Antinociceptive) property of Moringa oleifera ethanol leaf extract in albino rats,
J. Adv. Biol. Biotechnol.,
2014,
1, 23–29. [
Crossref], [
Google Scholar], [
Publisher]
[22] M.H.G. Dehghan, Phytochemical and pharmacological evaluation of ethanolic Extract of Moringa Oleifera as neuroprotective agent in vincristine induced peripheral neuropathy,
J. Sci. Technol.,
2022,
7, 1–18. [
Crossref], [
Pdf], [
Publisher]
[23] M.S. Rajput, N.P. Nirmal, S.J. Nirmal, C. Santivarangkna, Bio-actives from Caesalpinia sappan L.: Recent advancements in phytochemistry and pharmacology,
S Afr J Bot,
2022,
151, 60–74. [
Crossref], [
Google Scholar], [
Publisher]
[24] M.R.A. Syamsunarno, R. Safitri, Y. Kamisah, Protective effects of caesalpinia sappan Linn. and its bioactive compounds on cardiovascular organs,
Front. Pharmacol.,
2021,
12. [
Crossref], [
Google Scholar], [
Publisher]
[25] N.M. Saptarini, D.A. Deswati, Analgesic and antipyretic activities of ethanolic extract of sappan wood (Caesalpinia sappan l.) leaves,
Res. J. Pharm. Technol.,
2021,
14, 5213–5216. [
Crossref], [
Google Scholar], [
Publisher]
[26] F.A. Fajrin, A.E. Nugroho, A. Nurrochmad, & R. Susilowati, Molecular docking analysis of ginger active compound on transient receptor potential cation channel subfamily V member 1 (TRPV1),
Indones J Chem,
2018,
18, 179–185. [
Crossref], [
Google Scholar], [
Publisher]
[27] S.F. Jasim, Y.F. Mustafa, Synthesis and antidiabetic assessment of new coumarin-disubstituted benzene conjugates: An in silico–in virto study,
J. Med. Chem. Sci.,
2022, 5, 887–899. [
Crossref], [
Google Scholar], [
Publisher]
[28] M.H. Yang, S.H. Jung, G. Sethi, K.S. Ahn, Pleiotropic pharmacological actions of capsazepine, a synthetic analogue of capsaicin, against various cancers and inflammatory diseases,
Molecules,
2019,
24, 995. [
Crossref], [
Google Scholar], [
Publisher]
[29] M.I. Azevedo, G. Brito, D. Wong, The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy,
Mol. Pain,
2013,
9. [
Crossref], [
Google Scholar], [
Publisher]
[30] W. Gao, Y. Zan, Z.J. Wang, X. Hu, F. Huang, Quercetin ameliorates paclitaxel-induced neuropathic pain by stabilizing mast cells, and subsequently blocking PKCε-dependent activation of TRPV1,
Acta Pharmacol Sin,
2016,
37, 1166–1177. [
Crossref], [
Google Scholar], [
Publisher]
[31] F. Yang, J. Zheng, Understand spiciness: mechanism of TRPV1 channel activation by capsaicin,
Protein Cell,
2017,
8, 169–177. [
Crossref], [
Google Scholar], [
Publisher]
[32] G. Ye, C. Lin, Y. Zhang, Z. Ma, Y. Chen, L. Kong, L. Yuan, T. Ma, Quercetin alleviates neuropathic pain in the rat CCI model by mediating AMPK/MAPK pathway,
J. Pain Res.,
2021,
14, 1289–1301. [
Crossref], [
Google Scholar], [
Publisher]
[33] D.A. Valério, S.R. Georgetti, D.A. Magro, R. Casagrande, T.M. Cunha, F.T.M.C. Vicentini, S.M. Vieira, M.J.V. Fonseca, S.H. Ferreira, F.Q. Cunha, W.A. Verri, Quercetin reduces inflammatory pain: Inhibition of oxidative stress and cytokine production,
J. Nat. Prod.,
2009,
72, 1975–1979. [
Crossref], [
Google Scholar], [
Publisher]
[34] S.M. Borghi, F.A. Pinho-Ribeiro, V. Fattori, A.J. Bussmann, J.A. Vignoli, D. Camilios-Neto, R. Casagrande, & W. A. Verri, Quercetin inhibits peripheral and spinal cord nociceptive mechanisms to reduce intense acute swimming-induced muscle pain in mice,
PLoS ONE,
2016,
11. [
Crossref], [
Google Scholar], [
Publisher]
[35] Z. Fazlin, T. Myo, D.M. Fauzi, M. Resni, M. Noorzaid, Neuroprotective effects of ellagic acid, rutin and p-coumaric acid on diabetic neuropathy rats,
Asian J. Med. Health Sci.,
2022,
5, 42–57. [
Google Scholar], [
Publisher]
[36] M.T. Taghi, B. Naghizadeh, B. Ghorbanzadeh, Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain,
Eur. J. Pharmacol.,
2013,
707, 46–53. [
Crossref], [
Google Scholar], [
Publisher]
[37] S. Shahidi, A. Komaki, S. Raoufi, I. Salehi, M. Zarei, M. Mahdian, C. Shahidi, The anti-nociceptive effect of ellagic acid in streptozotocin-induced hyperglycemic rats by oxidative stress involvement,
BCN,
2021,
12, 861–872. [
Crossref], [
Google Scholar], [
Publisher]
[38] G.W. Pasternak, Y.X. Pan, Mu opioids and their receptors: evolution of a concept,
Pharmacol. Rev.,
2013,
65, 1257–1317. [
Crossref], [
Google Scholar], [
Publisher]
[39] P.C. Scherer, N.W. Zaccor, N.M. Neumann, C. Vasavda, R. Barrow, A.J. Ewald, F. Rao, C.J. Sumner, S.H. Snyder, TRPV1 is a physiological regulator of μ-opioid receptors,
Proc. Natl. Acad. Sci. USA,
2017,
114, 13561–13566. [
Crossref], [
Google Scholar], [
Publisher]
[40] N. Abdullah, C. Altier, TRPV1 and MOR working in tandem: implications for pain and opioids use,
Neuropsychopharmacol,
2020,
45, 225–226. [
Crossref], [
Google Scholar], [
Publisher]
[41] L. Staurengo-Ferrari, S.S. Mizokami, J.J. Silva, F.O.N. Da Silva, E.H.S. Sousa, L.G. Da França, M.L. Matuoka, S.R. Georgetti, M.M. Baracat, R. Casagrande, W.R. Pavanelli, W.A. Verri, The ruthenium NO donor, [Ru(bpy)2(NO)SO3](PF6), inhibits inflammatory pain: Involvement of TRPV1 and cGMP/PKG/ATP-sensitive potassium channel signaling pathway,
Pharmacol. Biochem. Behav.,
2013,
105, 157–165. [
Crossref], [
Google Scholar], [
Publisher]
[42] F. Ntalouka, A. Tsirivakou, Luteolin: A promising natural agent in management of pain in chronic conditions,
Front. Pain Res.,
2023,
4, 1–19. [
Crossref], [
Google Scholar], [
Publisher]
[43] M. Kim, J. Jung, N. Young, J. Hyung, J. Chung, The natural plant flavonoid apigenin is a strong antioxidant that effectively delays peripheral neurodegenerative processes,
Anat. Sci. Int.,
2019,
94, 285–294. [
Crossref], [
Google Scholar], [
Publisher]
[44] H. Yasar, A. Ersoy, G. N. Yazici, H. Suleyman, F.B. Özgeriş, Y. Kemal, The effect of lutein on paclitaxel-induced neuropathy and neuropathic pain in rats,
Int. J. Clin. Exp. Med.,
2020,
13, 4316–4323. [
Pdf], [
Google Scholar], [
Publisher]